AMAG PHARMACEUTICALS INC. 4
4 · AMAG PHARMACEUTICALS INC. · Filed May 10, 2017
Insider Transaction Report
Form 4
Grund Nicholas
Chief Commercial Officer
Transactions
- Tax Payment
Common Stock
2017-05-08$18.55/sh−3,483$64,610→ 48,517 total
Footnotes (1)
- [F1]Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 10,665 restricted stock units ("RSUs") on January 4, 2017. Due to the black-out policies implemented by AMAG Pharmaceuticals, Inc. (the "Issuer"), the shares of the Issuer's Common Stock underlying such vested RSUs were not delivered to the reporting person until May 8, 2017, at which time 3,483 shares were withheld to satisfy the reporting person's applicable tax obligations.